These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 4007273)
1. The control of biological medicinal products produced by recombinant DNA technology. Griffiths E Dev Biol Stand; 1985; 59():155-9. PubMed ID: 4007273 [TBL] [Abstract][Full Text] [Related]
2. Quality control of biologicals produced by r-DNA technology. Liu DT; Gates FT; Goldman ND Dev Biol Stand; 1985; 59():161-6. PubMed ID: 4007274 [TBL] [Abstract][Full Text] [Related]
3. USDA licensing policy for biologicals produced by R-DNA. Espeseth DA; Shibley GP; Joseph PL; van Deusen RA; Whetstone CA Dev Biol Stand; 1985; 59():167-73. PubMed ID: 4007275 [TBL] [Abstract][Full Text] [Related]
4. Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications. Jones AJ; O'Connor JV Dev Biol Stand; 1985; 59():175-80. PubMed ID: 4007276 [TBL] [Abstract][Full Text] [Related]
5. Quality control of biologicals produced by recombinant DNA techniques. WHO consultation. WHO Consultation Bull World Health Organ; 1983; 61(6):897-911. PubMed ID: 6609009 [TBL] [Abstract][Full Text] [Related]
6. Safety issues relating to the use of mammalian cells as hosts. Petricciani JC Dev Biol Stand; 1985; 59():149-53. PubMed ID: 3891461 [TBL] [Abstract][Full Text] [Related]
7. License requirements for recombinant DNA veterinary biologics in U.S.A. La Salle B Dev Biol Stand; 1985; 59():181-4. PubMed ID: 4007277 [TBL] [Abstract][Full Text] [Related]
8. Control of therapeutic goods produced by recombinant DNA technology. Breschkin A Dev Biol Stand; 1987; 67():207-11. PubMed ID: 3475226 [TBL] [Abstract][Full Text] [Related]
9. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing. Griffiths E Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093 [TBL] [Abstract][Full Text] [Related]
10. Characterization of gene therapy products and the impact of manufacturing changes on product comparability. Simek SL Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258 [TBL] [Abstract][Full Text] [Related]
11. Quality assurance of products manufactured by recombinant DNA technology. Introduction and elements of a philosophy. van Noordwijk J Arzneimittelforschung; 1988 Jul; 38(7):943-7. PubMed ID: 3207439 [TBL] [Abstract][Full Text] [Related]
12. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product. Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186 [TBL] [Abstract][Full Text] [Related]
13. Biologicals and vaccines: regulatory perspectives. Petricciani JC Dev Biol Stand; 1986; 63():15-9. PubMed ID: 3743903 [TBL] [Abstract][Full Text] [Related]
14. Specifications and quality control of a yeast-derived hepatitis B vaccine. Peetermans JH Postgrad Med J; 1987; 63 Suppl 2():97-100. PubMed ID: 3317364 [TBL] [Abstract][Full Text] [Related]
16. Methods of endotoxin removal from biological preparations: a review. Magalhães PO; Lopes AM; Mazzola PG; Rangel-Yagui C; Penna TC; Pessoa A J Pharm Pharm Sci; 2007; 10(3):388-404. PubMed ID: 17727802 [TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2005 Jun; 70(125):37861-2. PubMed ID: 15988855 [TBL] [Abstract][Full Text] [Related]
18. Laboratory control of biological products in Latin America. Greenberg L Bull Pan Am Health Organ; 1975; 9(1):27-31. PubMed ID: 1148451 [TBL] [Abstract][Full Text] [Related]
19. Successful development of recombinant DNA-derived pharmaceuticals. Werner RG; Pommer CH Arzneimittelforschung; 1990 Nov; 40(11):1274-83. PubMed ID: 2085342 [TBL] [Abstract][Full Text] [Related]